Asgers abekoppe-gevinst

from Genstart · host DR

Da WHO erklærer abekopper for en global sundhedskrise, stiger Asger Aamunds aktiekapital betydeligt. Han er nemlig storaktionær i den danske virksomhed Bavarian Nordic, der - som den eneste i verden - har en godkendt vaccine mod den blære-fremkaldende sygdom, der lige nu spreder sig over hele jorden. Følger der et særligt ansvar med det patent? Asger Aamund, stifter af Bavarian Nordic og tidligere bestyrelsesformand i virksomheden, fortæller vaccinens spektakulære historie. Vært: Anna Ingrisch.

Episode metadata supplied by the publisher feed · Published Aug 5, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Asgers abekoppe-gevinst

0:00 23:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Genstart?

This episode is 23 minutes long.

When was this Genstart episode published?

This episode was published on August 5, 2022.

Can I download this Genstart episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!